Envios by Ryan Van Laar

United States Patent 8,999,648

Translating a gene expression signature for multiple myeloma prognosis into a robust high-throughput assay for clinical use

RVL NYS CQ 2012-14

BreastPRS is a Gene Expression Assay that Stratifies Intermediate-Risk Oncotype DX Patients into High or Low-Risk for Disease Recurrence

BreastPRS SABCS 84x42 3col A

Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung cancer

Implementation of a novel microarray-based diagnostic test for cancer of unknown primary

Optimisation of cDNA Microarray Tumour Profiling and Molecular Analysis of Epithelial Ovarian Cancer

Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival

Presentation of Genomic Analysis Results With ChipDX

ChipDX February 2011 Flyer